Labat Africa Limited

ZAC 3.00As of Sun 8 Nov 2026, 12:00 UTC
JSE:LABHealthcare
Country South Africa
PE (Fwd) •••
TSR 10Y CAGR (19.69%)
Div yield 33.33%
ROE 127.97%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.12
PE TTM 0.277
TSR TTM (57.14%)
Mkt cap R 37.47M
ROIC 43.17%
SE Grade™
Value
Quality
Moat
Consensus
Reference
ZAC 3.69
23.03%
1.57%
Hold 5|8|4|3|8
2Q26
3Q26
4Q26
1Q27
Earnings per shareR
0.04
0.04
0.04
0.04
29.77%
18.54%
14.13%
12.43%
RevenueR M
4.151
4.256
4.148
4.224
3.35%
0.41%
(1.69%)
2.01%
Peers (US$2.268M)
Cap (US$)
PE
7.464M
68.07x
2.217M
—
Capital
TTM
5Y
10Y
Leveragex
0.103
(2.245)
(2.293)
EBIT/Intx
0.812
1.985
1.989
Own earn%
(85.79)
8.50
0.27
Sh yield%
26.60
17.81
18.10
Owners
Insiders/Inst%
2.95
64.75
Short interest%
0.75
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
17–26
$1 testx
—
Incr. ROIC%
0